<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Decreased phosphatidylcholine plasmalogens e A putative novel lipid signature in patients with stable coronary artery disease and acute myocardial infarction</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Iryna</forename><surname>Sutter</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Clinical Chemistry</orgName>
								<orgName type="institution">University and University Hospital of Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Competence Center for Integrated Human Physiology</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Roland</forename><surname>Klingenberg</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Cardiology and Cardiovascular Research</orgName>
								<orgName type="institution" key="instit1">University Heart Center</orgName>
								<orgName type="institution" key="instit2">University Hospital Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Alaa</forename><surname>Othman</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Clinical Chemistry</orgName>
								<orgName type="institution">University and University Hospital of Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="institution">Universit€ atsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="department">Institute of Social and Preventive Medicine</orgName>
								<orgName type="laboratory">Clinical Trials Unit</orgName>
								<orgName type="institution">University of Bern</orgName>
								<address>
									<settlement>Bern</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lucia</forename><surname>Rohrer</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Clinical Chemistry</orgName>
								<orgName type="institution">University and University Hospital of Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ulf</forename><surname>Landmesser</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Competence Center for Integrated Human Physiology</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Cardiology and Cardiovascular Research</orgName>
								<orgName type="institution" key="instit1">University Heart Center</orgName>
								<orgName type="institution" key="instit2">University Hospital Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Department of Cardiology</orgName>
								<address>
									<settlement>Charit</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Dierik</forename><surname>Heg</surname></persName>
							<affiliation key="aff5">
								<orgName type="institution">Universit€ atsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="department">Institute of Social and Preventive Medicine</orgName>
								<orgName type="laboratory">Clinical Trials Unit</orgName>
								<orgName type="institution">University of Bern</orgName>
								<address>
									<settlement>Bern</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Nicolas</forename><surname>Rodondi</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Department of Internal Medicine</orgName>
								<orgName type="institution">University Hospital Bern</orgName>
								<address>
									<settlement>Bern</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Francois</forename><surname>Mach</surname></persName>
							<affiliation key="aff8">
								<orgName type="institution">University Hospital Geneva</orgName>
								<address>
									<settlement>Cardiology</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stephan</forename><surname>Windecker</surname></persName>
							<affiliation key="aff9">
								<orgName type="department">Cardiovascular Center</orgName>
								<orgName type="institution">University Hospital Bern</orgName>
								<address>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christian</forename><forename type="middle">M</forename><surname>Matter</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Competence Center for Integrated Human Physiology</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Cardiology and Cardiovascular Research</orgName>
								<orgName type="institution" key="instit1">University Heart Center</orgName>
								<orgName type="institution" key="instit2">University Hospital Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Thomas</forename><forename type="middle">F</forename><surname>Lüscher</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Competence Center for Integrated Human Physiology</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Cardiology and Cardiovascular Research</orgName>
								<orgName type="institution" key="instit1">University Heart Center</orgName>
								<orgName type="institution" key="instit2">University Hospital Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Arnold</forename><surname>Von Eckardstein</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Clinical Chemistry</orgName>
								<orgName type="institution">University and University Hospital of Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Competence Center for Integrated Human Physiology</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
							<affiliation key="aff10">
								<orgName type="department">Competence Center for Systems Physiology and Metabolic Diseases</orgName>
								<orgName type="institution">ETH Zurich and University of Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Thorsten</forename><surname>Hornemann</surname></persName>
							<email>thorsten.hornemann@usz.ch</email>
							<affiliation key="aff0">
								<orgName type="department">Institute of Clinical Chemistry</orgName>
								<orgName type="institution">University and University Hospital of Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Competence Center for Integrated Human Physiology</orgName>
								<orgName type="institution">University of Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
							<affiliation key="aff10">
								<orgName type="department">Competence Center for Systems Physiology and Metabolic Diseases</orgName>
								<orgName type="institution">ETH Zurich and University of Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff11">
								<orgName type="department">Inst. for Clinical Chemistry</orgName>
								<orgName type="institution">University Hospital Zurich</orgName>
								<address>
									<addrLine>Raemistrasse 100</addrLine>
									<postCode>CH-8091</postCode>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Decreased phosphatidylcholine plasmalogens e A putative novel lipid signature in patients with stable coronary artery disease and acute myocardial infarction</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">495C60DEFDCABB33B1CD3C20B42175E4</idno>
					<idno type="DOI">10.1016/j.atherosclerosis.2016.01.003</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:21+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>Glycerophospholipids Sphingolipids Coronary artery disease Acute myocardial infarction</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Objective: Glycerophospholipids and sphingolipids are structurally heterogeneous due to differences in the O-and N-linked fatty acids and head groups.</s><s>Sphingolipids also show a heterogeneity in their sphingoid base composition which up to now has been little appreciated.</s><s>The aim of this study was to investigate the association of certain glycerophospholipid and sphingolipid species with stable coronary artery disease (CAD) and acute myocardial infarction (AMI).</s><s>Methods: The lipid profile in plasma from patients with stable CAD (n ¼ 18) or AMI (n ¼ 17) was compared to healthy subjects (n ¼ 14).</s><s>Sixty five glycerophospholipid and sphingolipid species were quantified by LC-MS.</s><s>The relative distribution of these lipids into lipoprotein fractions was analyzed.</s><s>Results: In the CAD cohort, 45 glycerophospholipid and sphingolipid species were significantly lower compared to healthy controls.</s><s>In the AMI group, 42 glycerophospholipid and sphingolipid species were reduced.</s><s>Four PC plasmalogens (PC33:1, PC33:2, PC33:3 and PC35:3) showed the most significant difference.</s><s>Out of eleven analyzed sphingoid bases, four were lower in the CAD and six in the AMI group.</s><s>Sphingosine-1-phosphate (S1P) levels were reduced in the AMI group whereas an atypical C16:1 S1P was lower in both groups.</s><s>Phosphatidylcholine and sphingomyelin species were exclusively present in lipoprotein particles, whereas lysophosphatidylcholines were mainly found in the lipoprotein-free fraction.</s><s>The observed differences were not explained by the use of statins as confirmed in a second, independent cohort.</s><s>Conclusions: Reduced levels of four PC plasmalogens (PC33:1, PC33:2, PC33:3 and PC35:3) were identified as a putatively novel lipid signature for CAD and AMI.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Introduction</head><p><s>Coronary artery disease (CAD) is a major cause of death and morbidity in the western world <ref type="bibr" target="#b0">[1]</ref>.</s><s>CAD is caused by the gradual development of atherosclerotic plaques in the arterial wall.</s><s>A rupture or erosion of plaques with subsequent total occlusion of an epicardial coronary artery may lead to acute myocardial infarction (AMI) <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b2">3]</ref>.</s><s>Recent data suggest that beyond established lipids risk factors like cholesterol and triacylglycerols also glycerophospholipids and sphingolipids contribute to atherogenesis <ref type="bibr" target="#b3">[4,</ref><ref type="bibr" target="#b4">5]</ref>.</s><s>Plasma glycerophospholipids and sphingolipids are mainly associated with lipoprotein particles [6e8] and form a lipid monolayer around the hydrophobic core of triacylglycerols and cholesteryl esters.</s><s>Prior work identified distinct lipid profiles of plasma, serum or lipoprotein particles in patients with <ref type="bibr">CAD [9e13]</ref>.</s><s>Hundreds of different glycerophospholipid and sphingolipid species were identified in plasma lipoproteins and atherosclerotic plaques <ref type="bibr" target="#b13">[14,</ref><ref type="bibr" target="#b14">15]</ref>.</s><s>In particular sphingolipids are structurally diverse because of a multiplicity in O-linked head groups and N-linked fatty acids.</s><s>Sphingolipids also show a significant heterogeneity in the sphingoid base composition which yet has been only little appreciated.</s><s>Sphingolipid de-novo formation is initiated by the conjugation of Lserine and acyl-CoA, a reaction catalyzed by the enzyme serine palmitoyltransferase (SPT).</s><s>Sphingoid bases, the product of this reaction are the common structural feature for all sphingolipid species.</s><s>The most abundant sphingoid bases in plasma is C 18 sphingosine, but SPT can also form other sphingoid bases in the range of C 14 eC 20 <ref type="bibr" target="#b15">[16]</ref>.</s><s>Under certain conditions, SPT also metabolizes L-alanine and glycine which forms an atypical category of 1deoxysphingolipids (1-deoxySLs) <ref type="bibr" target="#b16">[17,</ref><ref type="bibr" target="#b17">18]</ref> which were shown to be elevated in several metabolic conditions.</s></p><p><s>The aim of this study was to identify novel plasma lipid signatures for patients with CAD or AMI.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Materials and methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1.">Patients</head><p><s>Healthy subjects (n ¼ 14) were recruited from the local blood bank.</s><s>Exclusion criteria were the use of cardiovascular medication, positive cardiovascular family history, smoking (including cessation of smoking within 2 years prior to study enrollment), history of hypertension, elevated total cholesterol (!5.0 mmol/L), BMI &gt; 30 kg/m2, history of diabetes mellitus, evidence of relevant vascular or structural heart disease and/or a reduced LVEF (&lt;55%) on echocardiogramm.</s><s>The stable CAD group (n ¼ 18) was selected from patients with angiographically documented coronary artery stenosis !50%.</s><s>Exclusion criteria comprised an ACS within the preceding 6 months, systemic infectious, inflammatory or autoimmune disease, known severe renal dysfunction (serum creatinine &gt;220 mmol/L), known severe hepatic dysfunction (3x ULN for LFTs), neoplasm or other life-threatening disease with a life expectancy less than one year, extended surgery in the preceding 3 months and/or evidence of vascular or structural heart disease and/ or a reduced systolic LV function on echocardiogram or left ventricular angiogram.</s></p><p><s>Patients with AMI (n ¼ 17) were selected from the Inflammation in Acute Coronary Syndromes cohort (SPUM-ACS, NCT01000701).</s><s>SPUM-ACS inclusion criteria comprised both genders (aged !18 years) presenting within five days (preferably within 72 h) after onset of chest pain and a main diagnosis of STEMI, NSTEMI or unstable angina as described previously <ref type="bibr" target="#b18">[19]</ref>.</s></p><p><s>All patients gave written informed consent and the study was conducted with approval from the local ethics committee (EK-1680).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2.">Sampling of plasma</head><p><s>Blood was drawn from the antecubital vein in healthy subjects and from the femoral/radial artery at the time of diagnostic coronary angiography in patients with CAD or AMI, respectively.</s></p><p><s>Samples were centrifuged at 2700 g for 10 min at room temperature to obtain plasma, frozen and stored in aliquots at À80 C until serial measurement (no prior freeze-thaw cycles).</s><s>To avoid interassay differences all samples were extracted and analyzed in a single batch.</s><s>The person who performed the analysis was blinded to the patient's data by the use of numbered ID codes.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3.">Clinical chemistry</head><p><s>Plasma concentrations or activities of total cholesterol, triglycerides, LDL-C and HDL-C, glucose, creatine kinase, CK-MB, and troponin levels were determined by photometric tests or immunoassay by using the Cobas 8000 autoanalyzer from Roche diagnostics (Rotkreuz, Switzerland).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4.">Isolation of lipoproteins</head><p><s>Human lipoprotein fractions and the lipoprotein-free fraction (LFF) were isolated from plasma of three healthy blood donors by stepwise ultracentrifugation, as described previously <ref type="bibr" target="#b19">[20]</ref>.</s><s>Purity of lipoprotein fractions was confirmed by SDS-PAGE and Coomassie Blue staining.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.5.">Analysis of plasma glycerophospholipids and sphingolipids</head><p><s>Six lipid classes including phosphatidylglycerols (PGs), phosphatidic acids (PAs), phosphatidylethanolamines (PEs), phosphatidylcholines (PCs), sphingomyelins (SMs) and ceramides/ hexosylceramides (Cers/HexCers) were analyzed.</s><s>Lipids were quantified in relation to internal standards (200 ng) including PG(17:0/17:0), LPG(17:1/0:0), PA(14:0/14:0), LPA(17:0/0:0), PE(14:0/ 14:0), LPE(17:1/0:0), PC(14:0/14:0), PC(24:0/24:0), LPC(17:0/0:0), SM (d18:1/12:0) and Cer(d18:1/17:0) (Avanti Polar Lipids, Alabaster, AL, USA).</s><s>20 ml plasma was extracted with 375 ml of methanol/ chloroform (2:1 v/v).</s><s>After vortexing, 100 ml water and 125 ml chloroform were added, agitated (15 min), centrifuged <ref type="bibr">(16,</ref> Precursor ion scan of m/z 184, specific for phosphocholine was used for PC, SM and LPC lipids.</s><s>Neutral loss scan of m/z 141 was used for PEs and precursor scanning of m/z 264 was applied for Cer and HexCer species.</s><s>Data were analyzed in Xcalibur (version 2.0.6,</s><s>Thermo Scientific).</s><s>Identification of molecular species was performed by lipid mass spectrum analysis software (LIMSA) <ref type="bibr" target="#b20">[21]</ref>.</s></p><p><s>The assignment of glycerophospholipids includes total numbers of carbons and double bonds in two acyl chains.</s><s>The SM assignment comprises total numbers of carbons and double bonds in the sphingoid base and N-linked fatty acid.</s><s>Hexosylceramide species include isomeric glucosyl-and galactosylceramides.</s><s>For identified Cers and HexCers, molecular structures are reported.</s><s>Quantification was done in relation to the respective internal standards.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.6.">Quantification of sphingosine-1-phosphate species</head><p><s>Sphingosine-1-phosphates (S1Ps) in plasma samples were determined by LC-MS as described previously <ref type="bibr" target="#b21">[22]</ref>.</s><s>Concentrations of S1P species were measured in 25 ml of plasma spiked with 10 pmol internal standard 18:1-D7S1P (Avanti Polar Lipids, Alabaster, AL, USA).</s><s>Analysis of S1P species included the quantification of 16:1-S1P, 17:1-S1P, 18:1-S1P and 18:0-S1P lipids.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.7.">Quantification of sphingoid bases</head><p><s>The profile of 11 plasma sphingoid bases was analyzed by LC-MS as described earlier <ref type="bibr" target="#b22">[23]</ref>.</s><s>d7-sphingosine (D7SO) and d7sphinganine (D7SA) (200 pmol each) were used as internal standards (Avanti Polar Lipids, Alabaster, AL, USA).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.8.">Statistical analysis</head><p><s>Statistical analysis was performed using SPSS, version 19 (IBM Corporation, Somers NY, USA).</s><s>Normality of the data was determined by using the Kolmogorov-Smirnov test.</s><s>For variables which did not show a normal distribution, univariate statistics was done using Kruskal-Wallis and the Mann-Whitney U tests.</s><s>Categorical variables were compared using the Chi-square test.</s><s>Spearman rank tests were used to describe the correlations of plasma glycerophospholipids and sphingolipids with total cholesterol, LDL-C and HDL-C levels.</s><s>The p values were adjusted for multiple comparisons by applying the Benjamini-Hochberg procedure <ref type="bibr" target="#b23">[24]</ref>.</s><s>Adjusted (adj.)</s><s>p values of &lt;0.05 were considered statistically significant.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1.">Patient characteristics</head><p><s>Here we compared the plasma lipid profile between healthy subjects and patients with stable CAD (n ¼ 18) or AMI (n ¼ 17).</s><s>The age of the patients ranged between 43 and 77 years.</s><s>On average, healthy subjects (56.4 ± 7.5 years) were ten and patients with CAD (61.3 ± 8.3 years) five years younger than patients with AMI (66.8 ± 10.0 years).</s><s>Features of acute myocardial infarction, including elevated levels of troponin T, NT-proBNP, creatine kinase and CK-MB were higher in the AMI group (Table <ref type="table">1</ref>).</s><s>Prevalence of smoking was significantly higher in CAD and AMI group.</s><s>Average BMI was higher in patients with CAD compared to healthy subjects.</s><s>LDL-C and total cholesterol levels were lower in patients with stable CAD and AMI due to statin treatment.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2.">Plasma lipidome e alterations in patients with CAD and AMI</head><p><s>Sixty-five lipid species were analyzed in this study.</s><s>As statin use was significantly higher in the CAD and AMI group (Table <ref type="table">1</ref>) we first tested for an influence of statins on the analyzed lipids species by comparing CAD patients with and without statin treatment (Table <ref type="table" target="#tab_1">2</ref>).</s><s>No significant differences for the analyzed glycerophospholipid and sphingolipid species were observed between the two groups.</s></p><p><s>Next we compared the same lipid profile between healthy subjects and patients with CAD and AMI.</s><s>Univariate statistics revealed significant changes in the plasma lipid profile for patients with stable CAD and AMI compared to healthy individuals (Table <ref type="table" target="#tab_3">3</ref>).</s><s>The total levels of PC, LPC, PE, SM and Cer/HexCer lipids were generally lower in patients with stable CAD and AMI compared to healthy subjects (Table <ref type="table" target="#tab_3">3</ref>).</s><s>Total Cer and HexCer were further reduced in patients with AMI compared to the CAD group.</s><s>Comparing the individual lipid species we observed differences in 45 molecular species (19 PCs, 4 LPCs, 5 PEs, 12 SMs and 5 Cers/ HexCers) for the CAD and differences in 42 lipid species (15 PCs, 2 LPCs, 9 PEs, 11 SMs and 5 Cers/HexCers) for the AMI group in comparison to healthy subjects (Table <ref type="table" target="#tab_3">3</ref>).</s></p><p><s>Sphingoid bases are the shared structural component for all sphingolipids.</s><s>C18 sphingosine (d18:1) is typically the most abundant sphingoid base in plasma although a wide range of other sphingoid bases can be found too.</s><s>For sphingoid base analysis, total sphingolipids were extracted from plasma samples and hydrolyzed to remove the conjugated N-acyl chain and head groups.</s><s>It is important to note that the here reported sphingoid base concentrations refer to the total levels of a given sphingoid base in plasma irrespective of the sphingolipid specie where it was originally contained (e.g Cer, hexCer, SM etc).</s><s>In the CAD and AMI group, we observe lower plasma levels for C 17 SO, C 18 SO, C 18 SA and C 18 SAdiene Table <ref type="table">1</ref> Clinical characteristics of the study population.</s><s>Values are means ± SD or percentages for scale or categorical variables.</s><s>Statistical significance was determined by the Kruskal-Wallis (multiple group comparisons), and by the Mann-Whitney U test (two group comparisons).</s><s>p values for the categorical variables were calculated by using Chi-square test.</s><s>p values were adjusted for multiple testing by using the Benjamini-Hochberg procedure.</s><s>(Significant results are marked bold,* variables were measured before hospital discharge).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Characteristics</head><p><s>Healthy  based sphingolipids compared to healthy subjects but no difference between patients with CAD and AMI (Table <ref type="table" target="#tab_3">3</ref>).</s><s>Plasma levels of C16SO and C16SA were significantly lower in patients with AMI compared to healthy controls (Table <ref type="table" target="#tab_3">3</ref>).</s><s>1-Deoxysphingoid bases were not significantly altered between the groups.</s><s>The analysis of S1P species showed the presence of canonical 18:1-S1P but also of other S1P species, including 16:1-S1P, 17:1-S1P and 18:0-S1P.</s><s>Canonical (18:1) S1P was lower in patients with AMI compared to healthy individuals (Table <ref type="table" target="#tab_3">3</ref>) whereas an atypical 16:1-S1P was lower in both groups (Table <ref type="table" target="#tab_3">3</ref>).</s><s>Also 17:1-S1P was detectable but levels were below the limit of quantification (0.04 mM).</s></p><p><s>For further analysis, lipid and clinical data were arranged as volcano plots, showing the relative difference (x-axes) versus significance (y-axes).</s><s>The analyzed lipid species were divided into four groups: 1. glycerophospholipids including even-chain PCs, PEs, LPCs and PGs; 2. glycerophospholipids including odd-chain PCs; 3. sphingolipids including SMs, Cers/HexCers, S1Ps and sphingoid bases and 4. clinical measures.</s><s>Comparisons of healthy subjects vs. patients with CAD are shown in Fig. <ref type="figure" target="#fig_1">1A</ref>, comparisons of healthy subjects vs. patients with AMI in Fig. <ref type="figure" target="#fig_1">1B</ref>, and comparisons of CAD vs. AMI in Fig. <ref type="figure" target="#fig_1">1C</ref>.</s><s>The analysis revealed four odd-chain PC species (PC33:1, PC33:2, PC33:3 and PC35:3) to be the most significantly lowered species in patients with CAD compared to healthy subjects (Fig. <ref type="figure" target="#fig_1">1A</ref>).</s><s>The same odd-chain PC species were found to be lowered in the AMI group (Fig. <ref type="figure" target="#fig_1">1B</ref>).</s><s>Comparing CAD and AMI did not reveal differences in the lipid species but differences in some clinical variables including troponin, creatine kinase and CK-MB (Fig. <ref type="figure" target="#fig_1">1C</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3.">Structural analysis identifies odd-chain phosphatidylcholines as PC plasmalogens</head><p><s>The four identified odd-chain PC species (PC33:1, PC33:2, PC33:3 and PC35:3) could be either PCs with an odd number of carbons or PC plasmalogens with a vinyl-ether bond at the sn-1 position of the glycerol backbone.</s><s>Comparing the MS/MS fragmentation pattern of these species to a commercial standard we already identified PC35:3 as a PC(P-18:0/18:2) plasmalogen in a different study <ref type="bibr" target="#b12">[13]</ref>.</s><s>A similar structural analysis of the PC33:1, PC33:2 and PC33:3 species confirmed them as plasmalogens PC(P-18:0/16:0), PC(P-16:0/18:1) and PC(P-16:0/18:2), respectively.</s><s>The identity of other odd-chain PCs species in the dataset was not further investigated.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.4.">Plasma glycerophospholipids and sphingolipids correlate with cholesterol levels</head><p><s>Most of the identified glycerophospholipids and sphingolipids showed a significant correlation with total cholesterol and LDL-C (Fig. <ref type="figure" target="#fig_2">2</ref>).</s><s>Correlation with HDL-C was also seen for most species but less pronounced.</s><s>Among all glycerophospholipid and sphingolipid species, PC33:1, PC33:2, PC33:3 and PC35:3 showed the strongest correlation with HDL-C (r ¼ 0.81, r ¼ 0.71, r ¼ 0.75 and r ¼ 0.68, respectively).</s><s>Furthermore, total cholesterol and LDL-C correlated strongly with the sphingoid bases C18SO (r ¼ 0.93 and r ¼ 0.86, respectively) and C17SO (r ¼ 0.85 and r ¼ 0.81, respectively).</s><s>Saturated LPC species correlated more with total cholesterol and LDL-C than with HDL-C.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.5.">Glycerophospholipid and sphingolipid levels in the lipoprotein fractions</head><p><s>Because of the strong correlations between the individual lipoproteins and plasma glycerophospholipids and sphingolipid species, we analyzed the distribution of these lipids across the major lipoprotein fractions.</s><s>Lipoproteins were isolated from plasma of three healthy volunteers and the lipid profile analyzed in Chylomicrons/VLDL, LDL, HDL and in the lipoprotein-free fraction (LFF).</s><s>Species for PC, SM and LPC were detected in all plasma lipoprotein fractions.</s><s>PE and Cer/HexCer species were also present in lipoproteins, but at levels below the limit of quantification.</s><s>Neither PG nor PA lipids were identified in the lipoprotein or LFF fractions.</s></p><p><s>The relative percentages of total PC, SM and LPC lipids in the individual lipoprotein fractions are shown in Fig. <ref type="figure" target="#fig_3">3AeC</ref>.</s><s>The percentages of the individual PC, SM and LPC species relative to the total concentration of a given species in all lipoprotein fractions is  shown in Fig. <ref type="figure" target="#fig_3">3DeF</ref>.</s><s>PCs were more prominent in HDL (Fig. <ref type="figure" target="#fig_3">3A</ref>).</s><s>55% of total PCs were found in the HDL, approximately 34% were found in the LDL, 9% were found in the LFF and 2% of PCs were found in the combined CM/VLDL fractions.</s><s>Odd and even-chain PC species showed a similar distribution, with HDL being the major carrier of these lipids (Fig. <ref type="figure" target="#fig_3">3D</ref>).</s><s>For SM, 56% was found in LDL, 36% in HDL, 5% in LFF and 2% in CM/VLDL (Fig. <ref type="figure" target="#fig_3">3B, E</ref>). 80% of the total LPC species were found in the LFF, indicating that plasma LPCs are primarily bond to albumin (Fig. <ref type="figure" target="#fig_3">3C</ref>).</s><s>Small amounts of LPCs were present in LDL (11%) and HDL (7%).</s><s>A prominent difference in the lipoprotein distribution was seen for LPC18:0, when compared to other LPC species (Fig. <ref type="figure" target="#fig_3">3F</ref>).</s><s>The proportion of LPC18:0 was decreased by 20% in the LFF and increased by 11% in the LDL fraction relative to the proportion of LPC16:0.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Discussion</head><p><s>In our study we found significant differences in the lipid profile between healthy subjects and patients with stable CAD or AMI.</s><s>In the CAD group, plasma concentrations of 45 glycerophospholipids and sphingolipid species as well as an atypical 16:1-S1P were significantly lower compared with healthy subjects.</s><s>Also sphingolipids which are formed on a C 17 SO, C 18 SO, C 18 SA and C 18 SAdiene sphingoid base backbone were significantly lower.</s><s>In the AMI group, 42 plasma lipid species were significantly reduced compared to healthy subjects.</s><s>However, the observed differences were more related to CAD than AMI as only minor differences in the lipid profile were seen between the CAD and AMI group.</s><s>The observed differences seem to be independent of statin use as we did not see a significant effect of a cholesterol lowering therapy (statins) on glycerophospholipids and sphingolipid levels.</s></p><p><s>Four odd-chain PC species (PC33:1, PC33:2, PC33:3 and PC35:3), identified as PC plasmalogens were the most significantly altered lipids between the healthy and the CAD/AMI group.</s><s>Reduced plasmalogen plasma levels were reported previously for hypertensive and obese patients <ref type="bibr" target="#b24">[25,</ref><ref type="bibr" target="#b25">26]</ref> as well as for patients with CAD <ref type="bibr" target="#b8">[9]</ref>.</s><s>Decreased levels of HDL-associated PE plasmalogens were reported in patients with low HDL-C levels and in acute-phase HDL Published in final edited form as: Atherosclerosis.</s><s>2016 Mar;246:130-40.</s><s>doi: 10.1016/j.atherosclerosis.2016.01.003 <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b26">27]</ref>.</s><s>Comparing the individual lipoprotein fractions showed that PC33:1, PC33:2, PC33:3 and PC35:3 are largely associated with HDL which partly explains the strong positive correlations of these lipids with HDL-C as seen by us and others <ref type="bibr" target="#b27">[28]</ref>.</s></p><p><s>The physiological functions of plasmalogens are poorly understood.</s><s>It is unclear whether decreased levels of PC plasmalogens are due to metabolic effects in CAD and AMI or whether plasmalogens play an active role in the pathogenesis of CAD.</s><s>Plasmalogens possess antioxidant properties due to their ability to scavenge oxygen radicals <ref type="bibr" target="#b28">[29]</ref>.</s><s>Evidence from in vitro studies indicated that plasmalogens are capable of reducing the oxidation of cell membrane cholesterol, polyunsaturated fatty acids and LDL [30e32].</s><s>Thus, low levels of PC plasmalogens may be indicators of increased oxidative stress which may explain why PC plasmalogens, but not polyunsaturated PCs, were lower in patients with CAD and AMI.</s></p><p><s>Our analysis of the sphingoid base profile indicated a reduction of certain sphingoid bases in patients with CAD and AMI.</s><s>This is in line with significantly reduced plasma levels of certain SM species in patients with CAD and AMI.</s><s>However, 1-deoxyphingolipids (doxSA and doxSO), recently found as predictive biomarkers for the risk to develop type 2 diabetes mellitus <ref type="bibr" target="#b22">[23,</ref><ref type="bibr" target="#b32">33]</ref> were not different between healthy controls and patients with CAD or AMI.</s></p><p><s>Our analysis also revealed the presence of various S1P species, including typical 18:1-S1P 18:1) and atypical 16:1-S1P, 17:1-S1P and 18:0 SA1P.</s><s>Different S1P species were previously reported in plasma of healthy subjects <ref type="bibr" target="#b33">[34]</ref>, however, the existence of native 17:1-S1P was here reported for the first time.</s><s>Among the phosphorylated sphingosines, the canonical S1P (18:1) was the most abundant and found to be lowered in AMI group.</s><s>In contrast, 16:1-S1P, was diminished in plasmas of patients with CAD and AMI compared to healthy subjects.</s><s>Also other studies reported reduced S1P levels in plasma and HDL of patients with CAD <ref type="bibr" target="#b21">[22,</ref><ref type="bibr" target="#b34">35]</ref> as well as a significant inverse association of S1P (18:1) and SA1P (18:0) levels in the HDL-containing fraction of serum with the occurrence of ischemic heart disease <ref type="bibr" target="#b35">[36]</ref>.</s><s>In our study we did not see any significant association between plasma 18:0-SA1P levels and CAD or AMI.</s><s>Canonical S1P (18:1) is an important regulator of vascular function as well as immune and inflammation responses.</s><s>HDL is the major carrier of S1P in plasma and HDL bound S1P was reported to mediate several atheroprotective properties HDL <ref type="bibr" target="#b35">[36]</ref>, <ref type="bibr" target="#b36">[37]</ref>.</s><s>Therefore, differences in the concentration and composition of S1Ps in plasmas of healthy controls and patients with either acute or chronic cardiovavascular disease may reflect differences in atheroprotective plasma functions.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.1.">Limitations</head><p><s>This study was designed as a purely explorative approach to identify novel lipid signatures in patients with CAD and AMI.</s><s>Due to the small group sizes it was not possible to adjust for all potential confounders such as HDL-C, LDL-C, TG or medications without the risk of over fitting.</s><s>This might introduce a bias in particular for the observed associations with HDL-C which is generally lower in the CAD patients.</s><s>However, not all analyzed lipid species showed the same association with HDL-C indicating that changes in total HDL-C plasma levels are also associated with alterations in the lipid composition of HDL.</s><s>Further lipid species might show significant changes when validating the study in a bigger cohort.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.">Conclusions and perspectives</head><p><s>In conclusion, we found that plasma levels of various glycerophospholipid and sphingolipid species are reduced in patients with CAD and AMI.</s><s>Among them, PC33:1, PC33:2, PC33:3 and PC35:3, identified as plasmalogens PC(P-18:0/18:2), PC(P-18:0/ 16:0), PC(P-16:0/18:1) and PC(P-16:0/18:2), were the most significantly altered species in the plasma of patients with CAD.</s><s>Reduced plasmalogen levels might be indicators for oxidative stress as it is typically seen in patients with CAD.</s><s>We also found that these PC species are preferentially localized in HDL particles and correlate positively with HDL-C levels.</s><s>However, as this was an explorative study to find novel lipid signatures the observed associations need to be validated in a larger cohort which allows to adjust for more potential confounders in multivariate statistical tests.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>100 Âg for 5 min at 25 C) and the lower phase collected.</s><s>Again 250 ml chloroform was added, agitated (15 min) and centrifuged.</s><s>The lower phases were combined and evaporated under a stream of nitrogen.</s><s>Analysis was done on a TSQ Quantum Access triple quadrupole connected to a Rheos 2200 pump.</s><s>Separation was done on a diol silica-based column (QS Uptisphere 6 OH, 150 Â 2.1 mm, 5 mm).</s><s>Mobile phase (A) was hexane/isopropanol/water (70:30:2 v/ v) including 15 mM NH 4 COOH; and (B) isopropanol/water (50:2 v/ v) including 15 mM NH 4 COOH at a flow rate of 0.35 ml/min.</s><s>Gradient was 0e7 min A/B (%) 80/20; 8e10 min A/B (%) 60/40, 11e23 min A/B (%) 40/60 and 25e30 min A/B (%) 80/20.</s><s>Dried material was reconstituted in 200 ml of mobile phases A (80%) and B (20%) an injected (10 ml) into the LC-MS.</s><s>Neutral loss and precursor scans were used to detect specific glycerophospholipids and sphingolipids.</s><s>A neutral loss scan of m/z 115 and 189 from [M þ NH 4 ] þ ions was used for the analysis of PA and PG lipids.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 1 .</head><label>1</label><figDesc><div><p><s>Fig. 1.</s><s>Volcano plots illustrating the relative differences between healthy subjects and patients with CAD or AMI.</s><s>The x axis reflects the change (displayed as -log(fold change) whereas the y axis reflects the significance of change (displayed as -log(adj.</s><s>p value).</s><s>p values were calculated by the Mann-Whitney U test.</s><s>Colored dots represent the individual groups (blue, GPLs; green, SMs, Cers/HexCers, S1Ps and sphingoid bases; crimson, odd-chain PCs; grey, clinical measures).</s><s>The p values were adjusted for multiple comparisons according to the Benjamini-Hochberg procedure.</s><s>The dashed horizontal line reflects an adj.</s><s>p &lt; 0.05.</s><s>(AMI, acute myocardial infarction; CAD, coronary artery disease; H, healthy subjects; PC, phosphatidylcholine; GPL, glycerophospholipids; SL, sphingolipid).</s><s>(For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)</s></p></div></figDesc><graphic coords="7,58.39,318.05,468.95,366.01" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 2 .</head><label>2</label><figDesc><div><p><s>Fig. 2. Heat map of the spearman correlations between lipid species and cholesterol levels (total, HDL-C, LDL-C) over the entire cohort (N ¼ 49).</s><s>Red color indicates positive correlation, blue -negative.</s><s>(For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)</s></p></div></figDesc><graphic coords="8,110.67,66.73,383.75,416.01" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig. 3 .</head><label>3</label><figDesc><div><p><s>Fig. 3. Distribution of the total phosphatidylcholines, lysophosphatidylcholines and sphingomyelins (AeC) and of the individual species (DeF) in four major lipoprotein fractions.</s><s>Percentages of total phosphatidylcholines (PCs), lysophosphatidylcholines (LPCs) and sphingomyelins (SMs) are expressed as mean (AeC) and the species specific distribution (mean ± SD) relative to the total lipoprotein content of the individual lipids (DeF).</s><s>(CM/VLDL, chylomicron/very-low-density lipoprotein, HDL, high-density lipoprotein; LDL, lowdensity lipoprotein; LFF, lipoprotein-free fraction).</s></p></div></figDesc><graphic coords="9,108.00,66.73,369.83,391.24" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc><div><p><s>Plasma glycerophospholipids and sphingolipids in statin-treated and non-treated patients with CAD.Statistical significance was calculated by the Mann-Whitney U test.The p values were adjusted for multiple testing using the Benjamini-Hochberg procedure.Total lipids are presented for phosphatidylcholines (PCs), lysophosphatidylcholines (LPCs), phosphatidylethanolamines (PEs), phosphatidylglycerols (PGs), sphingomyelins (SMs), ceramide/hexosylceramides (Cers/HexCers).Glycerophospholipids are shown with total numbers of carbons and double bounds.SM species are summarized by numbers of carbons and double bounds in sphingoid base and N-linked fatty acid.Sphingosine-1-phosphate (S1P) species include numbers of carbons and double bonds in sphingoid base.HexCer species include isobaric glucosyl-and galactosylceramides. (n.d.-not detected).Published in final edited form as: Atherosclerosis.</s><s>2016 Mar;246:130-40.</s><s>doi: 10.1016/j.atherosclerosis.2016.01.003</s></p></div></figDesc><table><row><cell>Lipids (mM)</cell><cell>CAD statin-treated (n ¼ 10)</cell><cell>CAD statin-untreated (n ¼ 10)</cell><cell>Mann-Whitney U, adj. p values</cell></row><row><cell></cell><cell>Median(Min; Max)</cell><cell>Median(Min; Max)</cell><cell>CAD statin-treated vs</cell></row><row><cell></cell><cell></cell><cell></cell><cell>CAD statin-untreated</cell></row><row><cell>Total PC</cell><cell>795.3(614.8; 895.6)</cell><cell>823.6(692.2; 1195.8)</cell><cell>0.649</cell></row><row><cell>PC32:0</cell><cell>5.6(3.1; 7.8)</cell><cell>6.8(4.6; 9.5)</cell><cell>0.406</cell></row><row><cell>PC32:1</cell><cell>8.5(3; 15.5)</cell><cell>11.6(3.6; 15.4)</cell><cell>0.649</cell></row><row><cell>PC33:1</cell><cell>5.3(2.4; 9)</cell><cell>6.7(4.3; 9.3)</cell><cell>0.402</cell></row><row><cell>PC33:2</cell><cell>5.4(3.3; 12.3)</cell><cell>7(3.7; 10.5)</cell><cell>0.402</cell></row><row><cell>PC33:3</cell><cell>2.8(1.4; 5.9)</cell><cell>3.5(2.5; 7.8)</cell><cell>0.48</cell></row><row><cell>PC34:0</cell><cell>7.5(4.4; 11.7)</cell><cell>9.1(5; 11.6)</cell><cell>0.553</cell></row><row><cell>PC34:1</cell><cell>87.4(50; 126.5)</cell><cell>112.9(77.4; 152.8)</cell><cell>0.402</cell></row><row><cell>PC34:2</cell><cell>152.2(88; 222.1)</cell><cell>174.5(115.6; 297.4)</cell><cell>0.649</cell></row><row><cell>PC34:3</cell><cell>6.3(4.3; 9)</cell><cell>7.3(3.9; 10.6)</cell><cell>0.498</cell></row><row><cell>PC35:1</cell><cell>2.7(1; 3.5)</cell><cell>3.8(1.9; 5.5)</cell><cell>0.402</cell></row><row><cell>PC35:2</cell><cell>5.8(3.5; 6.3)</cell><cell>6.9(4.7; 11.2)</cell><cell>0.465</cell></row><row><cell>PC35:3</cell><cell>4.4(2.3; 8)</cell><cell>5.6(3.9; 9.7)</cell><cell>0.429</cell></row><row><cell>PC35:4</cell><cell>11.6(8.9; 17.9)</cell><cell>14.9(8.6; 19.3)</cell><cell>0.48</cell></row><row><cell>PC35:5</cell><cell>7.8(4.8; 15.3)</cell><cell>9.3(6.8; 12.9)</cell><cell>0.649</cell></row><row><cell>PC36:0</cell><cell>4(2.8; 5.7)</cell><cell>3.9(1.8; 6.6)</cell><cell>0.837</cell></row><row><cell>PC36:1</cell><cell>22.6(16.8; 31.2)</cell><cell>31.1(18.9; 42.7)</cell><cell>0.402</cell></row><row><cell>PC36:2</cell><cell>81.8(56.3; 115.2)</cell><cell>86.4(67.2; 144.3)</cell><cell>0.702</cell></row><row><cell>PC36:3</cell><cell>53(41.6; 68.1)</cell><cell>54.9(38; 77.5)</cell><cell>0.869</cell></row><row><cell>PC36:4</cell><cell>81.8(47.4; 103.9)</cell><cell>74.5(53.9; 120.8)</cell><cell>0.869</cell></row><row><cell>PC36:5</cell><cell>8.6(2; 19.8)</cell><cell>9.9(6.2; 15.6)</cell><cell>0.759</cell></row><row><cell>PC37:4</cell><cell>10.3(7.2; 15.9)</cell><cell>11.6(7.3; 14.2)</cell><cell>0.649</cell></row><row><cell>PC37:5</cell><cell>12.5(7.8; 16.4)</cell><cell>15.2(9.3; 21.6)</cell><cell>0.465</cell></row><row><cell>PC37:6</cell><cell>5.3(4.1; 9)</cell><cell>6.7(4.6; 9.9)</cell><cell>0.406</cell></row><row><cell>PC38:3</cell><cell>27.7(18.9; 37.1)</cell><cell>24.1(20.4; 43.3)</cell><cell>0.9</cell></row><row><cell>PC38:4</cell><cell>65.1(28.3; 75.7)</cell><cell>55.8(37.7; 101.3)</cell><cell>0.735</cell></row><row><cell>PC38:5</cell><cell>23.3(12.3; 30)</cell><cell>21.8(17.3; 27)</cell><cell>0.735</cell></row><row><cell>PC38:6</cell><cell>24.9(10.4; 34.5)</cell><cell>24(15.5; 31.5)</cell><cell>0.9</cell></row><row><cell>PC40:5</cell><cell>6.1(4.3; 7.4)</cell><cell>6.1(4.5; 9.6)</cell><cell>0.848</cell></row><row><cell>PC40:6</cell><cell>10.6(5; 14.1)</cell><cell>10.3(5.7; 15.7)</cell><cell>0.869</cell></row><row><cell>Total LPC</cell><cell>123.6(80.5; 154.7)</cell><cell>129.3(88.7; 179.2)</cell><cell>0.735</cell></row><row><cell>LPC16:0</cell><cell>67.4(44.8; 77.5)</cell><cell>75.2(53; 96.7)</cell><cell>0.48</cell></row><row><cell>LPC18:0</cell><cell>21.3(14.8; 27.7)</cell><cell>25.8(12; 34)</cell><cell>0.649</cell></row><row><cell>LPC18:1</cell><cell>14.7(8.8; 20.4)</cell><cell>14(9; 26.2)</cell><cell>0.702</cell></row><row><cell>LPC18:2</cell><cell>20.6(8.8; 37.9)</cell><cell>15.1(9.1; 32.3)</cell><cell>0.649</cell></row><row><cell>Total PE</cell><cell>14.2(6.3; 40.2)</cell><cell>16.3(8.2; 70)</cell><cell>0.759</cell></row><row><cell>PE34:2</cell><cell>0.9(0.2; 3.3)</cell><cell>1.6(0.3; 5.5)</cell><cell>0.649</cell></row><row><cell>PE35:2</cell><cell>0.1(0.03; 0.3)</cell><cell>0.3(0.1; 0.6)</cell><cell>0.402</cell></row><row><cell>PE36:4</cell><cell>1.3(0.8; 3.4)</cell><cell>1.7(0.5; 6.2)</cell><cell>0.837</cell></row><row><cell>PE36:3</cell><cell>0.8(0.1; 1.7)</cell><cell>0.9(0.2; 4.5)</cell><cell>0.759</cell></row><row><cell>PE36:2</cell><cell>2.8(0.7; 8.7)</cell><cell>3.5(0.6; 20.6)</cell><cell>0.759</cell></row><row><cell>PE36:1</cell><cell>0.6(0.1; 2.5)</cell><cell>0.8(0.1; 5.3)</cell><cell>0.56</cell></row><row><cell>PE37:5</cell><cell>0.4(0.03; 0.5)</cell><cell>0.8(0.2; 1.3)</cell><cell>0.402</cell></row><row><cell>PE37:4</cell><cell>0.2(0.1; 0.6)</cell><cell>0.2(0.1; 0.5)</cell><cell>0.848</cell></row><row><cell>PE38:6</cell><cell>2(0.5; 7.3)</cell><cell>2.2(0.9; 7.4)</cell><cell>0.702</cell></row><row><cell>PE38:5</cell><cell>1(0.6; 2.5)</cell><cell>1.3(0.5; 3.2)</cell><cell>0.804</cell></row><row><cell>PE38:4</cell><cell>3.9(1.9; 10.4)</cell><cell>4.4(2.1; 15.6)</cell><cell>0.804</cell></row><row><cell>Total PG</cell><cell>0.4(0.2; 0.7)</cell><cell>0.4(0.2; 1.7)</cell><cell>0.94</cell></row><row><cell>Total PA</cell><cell>n.d.</cell><cell>n.d.</cell><cell>e</cell></row><row><cell>Total SM</cell><cell>502.6(283.2; 628)</cell><cell>560.4(428.8; 702)</cell><cell>0.465</cell></row><row><cell>SM32:1</cell><cell>11.1(5.5; 18)</cell><cell>14.6(12; 17.7)</cell><cell>0.402</cell></row><row><cell>SM34:0</cell><cell>4(1.1; 5)</cell><cell>4.4(1.5; 6.1)</cell><cell>0.694</cell></row><row><cell>SM34:1</cell><cell>100.3(62.1; 136)</cell><cell>115.8(86.2; 161.1)</cell><cell>0.402</cell></row><row><cell>SM34:2</cell><cell>14.6(8.5; 22.8)</cell><cell>16.2(12.5; 28.3)</cell><cell>0.498</cell></row><row><cell>SM36:1</cell><cell>29.9(15.6; 42)</cell><cell>26.3(22.9; 46.6)</cell><cell>0.94</cell></row><row><cell>SM36:2</cell><cell>10.3(7.1; 14.3)</cell><cell>11.4(8.1; 16.8)</cell><cell>0.735</cell></row><row><cell>SM38:1</cell><cell>26.7(15; 32.1)</cell><cell>29.4(21.5; 36.6)</cell><cell>0.465</cell></row><row><cell>SM39:1</cell><cell>9.9(5.2; 16.7)</cell><cell>10.9(6.9; 15)</cell><cell>0.702</cell></row><row><cell>SM39:2</cell><cell>1.3(0.8; 2.3)</cell><cell>1.5(0.7; 1.9)</cell><cell>0.694</cell></row><row><cell>SM40:1</cell><cell>53.7(28.3; 66)</cell><cell>67.5(42.8; 95)</cell><cell>0.406</cell></row><row><cell>SM40:2</cell><cell>31.9(19; 39.5)</cell><cell>38.9(24.7; 49.5)</cell><cell>0.402</cell></row><row><cell>SM41:1</cell><cell>26.2(11.1; 38)</cell><cell>34.7(23.7; 42.7)</cell><cell>0.406</cell></row><row><cell>SM41:2</cell><cell>17.1(8.8; 25.6)</cell><cell>21.9(14.3; 31.2)</cell><cell>0.618</cell></row><row><cell>SM42:1</cell><cell>43(20.7; 52.3)</cell><cell>48.7(33.7; 75.6)</cell><cell>0.649</cell></row><row><cell>SM42:2</cell><cell>74.3(53.1; 113.7)</cell><cell>88.1(68.1; 123.5)</cell><cell>0.56</cell></row><row><cell></cell><cell></cell><cell></cell><cell>(continued on next page)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2 (</head><label>2</label><figDesc></figDesc><table><row><cell>continued )</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Lipids (mM)</cell><cell>CAD statin-treated (n ¼ 10)</cell><cell>CAD statin-untreated (n ¼ 10)</cell><cell>Mann-Whitney U, adj. p values</cell></row><row><cell></cell><cell>Median(Min; Max)</cell><cell>Median(Min; Max)</cell><cell>CAD statin-treated vs</cell></row><row><cell></cell><cell></cell><cell></cell><cell>CAD statin-untreated</cell></row><row><cell>SM42:3</cell><cell>28.9(21.3; 39.5)</cell><cell>34(19.9; 48.5)</cell><cell>0.702</cell></row><row><cell>Total Cer/HexCer</cell><cell>7.6(4.6; 13.4)</cell><cell>9.4(6.5; 21.5)</cell><cell>0.465</cell></row><row><cell>Cer(d18:1/24:0)</cell><cell>2.3(1.5; 3.5)</cell><cell>2.6(1.4; 5.4)</cell><cell>0.837</cell></row><row><cell>HexCer(d18:1/22:0)</cell><cell>1.4(0.8; 2.1)</cell><cell>1.3(0.5; 5.3)</cell><cell>0.848</cell></row><row><cell>HexCer(d18:1/23:0)</cell><cell>0.6(0.1; 1.5)</cell><cell>1.4(0.6; 2.4)</cell><cell>0.402</cell></row><row><cell>HexCer(d18:1/24:0)</cell><cell>2(1.1; 3.7)</cell><cell>2.8(1.4; 6.5)</cell><cell>0.429</cell></row><row><cell>HexCer(d18:1/24:1)</cell><cell>1.2(0.6; 2.6)</cell><cell>1.7(0.7; 2.9)</cell><cell>0.649</cell></row><row><cell>S1P species</cell><cell></cell><cell></cell><cell></cell></row><row><cell>16:1-S1P</cell><cell>0.1(0.07; 0.15)</cell><cell>0.11(0.07; 0.13)</cell><cell>0.649</cell></row><row><cell>17:1-S1P</cell><cell>n.d.</cell><cell>n.d.</cell><cell>e</cell></row><row><cell>18:1-S1P</cell><cell>0.45(0.39; 0.64)</cell><cell>0.55(0.51; 0.78)</cell><cell>0.402</cell></row><row><cell>18:0-S1P</cell><cell>0.08(0.04; 0.15)</cell><cell>0.06(0.03; 0.1)</cell><cell>0.649</cell></row><row><cell>Sphingoid bases of sphingolipids</cell><cell></cell><cell></cell><cell></cell></row><row><cell>C16SO</cell><cell>21.96(10.47; 29.5)</cell><cell>23.45(13.69; 27.98)</cell><cell>0.735</cell></row><row><cell>C16SA</cell><cell>0.56(0.25; 0.99)</cell><cell>0.55(0.27; 0.8)</cell><cell>0.9</cell></row><row><cell>C17SO</cell><cell>9.09(4.43; 10.95)</cell><cell>10.31(6.92; 14.97)</cell><cell>0.406</cell></row><row><cell>C18SO</cell><cell>89.08(57.3; 122.08)</cell><cell>112.52(79.23; 140.89)</cell><cell>0.498</cell></row><row><cell>C18SA</cell><cell>3.29(1.4; 5.36)</cell><cell>3.35(1.85; 6.49)</cell><cell>0.848</cell></row><row><cell>C18SAdiene</cell><cell>34.81(24.08; 46.54)</cell><cell>41.76(25.29; 51.8)</cell><cell>0.402</cell></row><row><cell>C19SO</cell><cell>3.56(1.71; 6.75)</cell><cell>3.34(1.73; 4.68)</cell><cell>0.869</cell></row><row><cell>C20SO</cell><cell>0.23(0.2; 0.37)</cell><cell>0.22(0.18; 0.34)</cell><cell>0.735</cell></row><row><cell>C20SA</cell><cell>0.04(0.02; 0.06)</cell><cell>0.04(0.02; 0.06)</cell><cell>0.848</cell></row><row><cell>doxSO</cell><cell>0.18(0.09; 0.39)</cell><cell>0.18(0.04; 0.4)</cell><cell>0.735</cell></row><row><cell>doxSA</cell><cell>0.09(0.04; 0.18)</cell><cell>0.09(0.02; 0.17)</cell><cell>0.735</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 3</head><label>3</label><figDesc><div><p><s>Comparison of plasma glycerophospholipids and sphingolipids in healthy subjects and patients with CAD and AMI (median with ranges).</s><s>Statistical significance was calculated by Kruskal-Wallis and Mann-Whitney U. Statistically significant results are indicated in bold.</s><s>p values were adjusted for multiple testing by the Benjamini-Hochberg procedure.</s><s>(AMI acute myocardial infarction; CAD, coronary artery disease; n.d., not detected).</s><s>Published in final edited form as: Atherosclerosis.</s><s>2016 Mar;246:130-40.</s><s>doi: 10.1016/j.atherosclerosis.2016.01.003</s></p></div></figDesc><table><row><cell>Lipids, mmol/l</cell><cell cols="2">Healthy subjects (n ¼ 14) CAD (n ¼ 18)</cell><cell>AMI (n ¼ 17)</cell><cell cols="4">Kruskal-Wallis, adj. p values Mann-Whitney U, adj. p values</cell></row><row><cell></cell><cell>Median(Min; Max)</cell><cell>Median(Min; Max)</cell><cell>Median(Min; Max)</cell><cell></cell><cell cols="3">H vs CAD H vs ACS CAD vs ACS</cell></row><row><cell>Total PC</cell><cell>829.3(692.3; 974.1)</cell><cell>725.6(522.7; 793.4)</cell><cell>670.4(595.9; 868.8)</cell><cell>&lt;0.001</cell><cell>0.002</cell><cell>0.001</cell><cell>0.38</cell></row><row><cell>PC32:0</cell><cell>6.8(5; 9.3)</cell><cell>5(3.3; 6.8)</cell><cell>5.6(3.5; 7.9)</cell><cell>0.002</cell><cell>0.002</cell><cell>0.02</cell><cell>0.314</cell></row><row><cell>PC32:1</cell><cell>9(4.9; 18.4)</cell><cell>6.2(3.2; 12)</cell><cell>7.3(4.2; 16.6)</cell><cell>0.094</cell><cell>0.05</cell><cell>0.2</cell><cell>0.697</cell></row><row><cell>PC33:1</cell><cell>7.7(7; 11.7)</cell><cell>5.5(2.5; 6.7)</cell><cell>5.8(3.9; 7.9)</cell><cell>&lt;0.001</cell><cell>&lt;0.001</cell><cell>0.001</cell><cell>0.584</cell></row><row><cell>PC33:2</cell><cell>10.1(6.7; 16)</cell><cell>5.9(2.6; 7.3)</cell><cell>6.4(4.3; 8.8)</cell><cell>&lt;0.001</cell><cell>&lt;0.001</cell><cell>0.001</cell><cell>0.314</cell></row><row><cell>PC33:3</cell><cell>5.6(3.6; 10.7)</cell><cell>2.8(1.7; 4.2)</cell><cell>3.2(1.6; 4.7)</cell><cell>&lt;0.001</cell><cell>&lt;0.001</cell><cell>&lt;0.001</cell><cell>0.584</cell></row><row><cell>PC34:0</cell><cell>9.3(6.3; 12.7)</cell><cell>7.1(4.3; 10.5)</cell><cell>7.4(5.4; 9.2)</cell><cell>0.004</cell><cell>0.015</cell><cell>0.002</cell><cell>0.877</cell></row><row><cell>PC34:1</cell><cell>92.6(74.9; 122.2)</cell><cell>76.2(42; 101.3)</cell><cell>81.7(51.7; 101.2)</cell><cell>0.043</cell><cell>0.026</cell><cell>0.108</cell><cell>0.681</cell></row><row><cell>PC34:2</cell><cell>187.8(156.6; 226.7)</cell><cell>135.9(72.2; 181.7)</cell><cell>129.5(98; 150.1)</cell><cell>&lt;0.001</cell><cell>&lt;0.001</cell><cell>&lt;0.001</cell><cell>0.471</cell></row><row><cell>PC34:3</cell><cell>8.7(5.1; 9.7)</cell><cell>5.5(3.6; 8.1)</cell><cell>4.5(3.2; 6.8)</cell><cell>&lt;0.001</cell><cell>0.002</cell><cell>0.001</cell><cell>0.391</cell></row><row><cell>PC35:1</cell><cell>10.3(8; 20.6)</cell><cell>7.4(3.5; 13.1)</cell><cell>7.5(5.8; 12.3)</cell><cell>0.004</cell><cell>0.006</cell><cell>0.006</cell><cell>0.863</cell></row><row><cell>PC35:2</cell><cell>8.1(7; 11.4)</cell><cell>6.3(2.9; 8.8)</cell><cell>5.9(4.2; 9.3)</cell><cell>&lt;0.001</cell><cell>0.001</cell><cell>0.002</cell><cell>0.681</cell></row><row><cell>PC35:3</cell><cell>7.5(6; 11)</cell><cell>5.1(2.3; 7.4)</cell><cell>5.1(2.7; 6.9)</cell><cell>&lt;0.001</cell><cell>&lt;0.001</cell><cell>&lt;0.001</cell><cell>0.932</cell></row><row><cell>PC35:4</cell><cell>15.4(8.7; 22.6)</cell><cell>13(7.4; 15.8)</cell><cell>13.1(7.6; 20.7)</cell><cell>0.031</cell><cell>0.015</cell><cell>0.116</cell><cell>0.644</cell></row><row><cell>PC35:5</cell><cell>11.9(6.1; 21)</cell><cell>8.4(4.4; 11.2)</cell><cell>9.2(4.7; 17.6)</cell><cell>0.041</cell><cell>0.024</cell><cell>0.148</cell><cell>0.482</cell></row><row><cell>PC36:0</cell><cell>5.3(3.8; 7.7)</cell><cell>4(2.6; 5.4)</cell><cell>4(2.4; 6.7)</cell><cell>0.005</cell><cell>0.003</cell><cell>0.022</cell><cell>0.877</cell></row><row><cell>PC36:1</cell><cell>32.7(23.9; 38.3)</cell><cell>22.7(13.4; 30.5)</cell><cell>22.7(17.1; 33.3)</cell><cell>&lt;0.001</cell><cell>&lt;0.001</cell><cell>0.002</cell><cell>0.681</cell></row><row><cell>PC36:2</cell><cell>106.7(77.7; 124.3)</cell><cell>78.6(51.9; 112.1)</cell><cell>72.1(52.8; 87.3)</cell><cell>&lt;0.001</cell><cell>0.001</cell><cell>&lt;0.001</cell><cell>0.509</cell></row><row><cell>PC36:3</cell><cell>48.7(44; 68.8)</cell><cell>44.7(29.7; 57.6)</cell><cell>40.7(29.8; 47.2)</cell><cell>0.001</cell><cell>0.09</cell><cell>0.001</cell><cell>0.175</cell></row><row><cell>PC36:4</cell><cell>70(39.4; 84.3)</cell><cell>73.7(44; 102)</cell><cell>74.4(47.4; 89.1)</cell><cell>0.682</cell><cell>0.506</cell><cell>0.595</cell><cell>0.932</cell></row><row><cell>PC36:5</cell><cell>8.8(5.8; 21.7)</cell><cell>8.8(1.3; 14.9)</cell><cell>9.2(2; 22.7)</cell><cell>0.725</cell><cell>0.491</cell><cell>0.877</cell><cell>0.768</cell></row><row><cell>PC37:4</cell><cell>12.7(8.3; 17)</cell><cell>11.4(6; 14.1)</cell><cell>10.8(7.3; 15.3)</cell><cell>0.226</cell><cell>0.235</cell><cell>0.159</cell><cell>0.863</cell></row><row><cell>PC37:5</cell><cell>17.3(11; 23.1)</cell><cell>13.5(7.7; 18.6)</cell><cell>14.5(9; 22.5)</cell><cell>0.026</cell><cell>0.018</cell><cell>0.085</cell><cell>0.509</cell></row><row><cell>PC37:6</cell><cell>8.6(5.9; 14.9)</cell><cell>6.2(3.4; 8)</cell><cell>7(3.3; 11.6)</cell><cell>0.003</cell><cell>0.002</cell><cell>0.028</cell><cell>0.286</cell></row><row><cell>PC38:3</cell><cell>21.6(11.2; 31.9)</cell><cell>23.5(14.4; 38.5)</cell><cell>19.8(10.9; 28.6)</cell><cell>0.157</cell><cell>0.506</cell><cell>0.386</cell><cell>0.091</cell></row><row><cell>PC38:4</cell><cell>49.5(28.9; 70.1)</cell><cell>60.7(41.5; 77.5)</cell><cell>60.6(38.4; 72.8)</cell><cell>0.091</cell><cell>0.047</cell><cell>0.29</cell><cell>0.482</cell></row><row><cell>PC38:5</cell><cell>19.3(11.8; 26.7)</cell><cell>18.3(8.2; 28.1)</cell><cell>18.9(12.2; 27.7)</cell><cell>0.979</cell><cell>0.95</cell><cell>0.877</cell><cell>0.863</cell></row><row><cell>PC38:6</cell><cell>17(12.7; 34.3)</cell><cell>20.7(9.3; 32.4)</cell><cell>18.7(11.1; 34.6)</cell><cell>0.259</cell><cell>0.148</cell><cell>0.815</cell><cell>0.38</cell></row><row><cell>PC40:5</cell><cell>5.3(3.3; 7.1)</cell><cell>5.9(3.5; 8.8)</cell><cell>5(2.8; 9.2)</cell><cell>0.387</cell><cell>0.34</cell><cell>0.904</cell><cell>0.343</cell></row><row><cell>PC40:6</cell><cell>7.7(5.1; 14.1)</cell><cell>10(5.5; 14.2)</cell><cell>8.5(5.7; 16.1)</cell><cell>0.201</cell><cell>0.104</cell><cell>0.506</cell><cell>0.482</cell></row><row><cell>Total LPC</cell><cell>179.2(156.8; 245.2)</cell><cell>136.3(105.3; 181.5)</cell><cell>136.6(110.5; 199.9)</cell><cell>&lt;0.001</cell><cell>0.001</cell><cell>0.004</cell><cell>0.623</cell></row><row><cell>LPC16:0</cell><cell>90.8(77.4; 121.1)</cell><cell>72.5(52.3; 95.9)</cell><cell>64.1(49.6; 104.2)</cell><cell>&lt;0.001</cell><cell>0.001</cell><cell>0.001</cell><cell>0.235</cell></row><row><cell>LPC18:0</cell><cell>30.7(26.4; 46.7)</cell><cell>25.6(20; 34.1)</cell><cell>22(15.7; 33.3)</cell><cell>0.001</cell><cell>0.006</cell><cell>0.002</cell><cell>0.098</cell></row><row><cell>LPC18:1</cell><cell>21.3(15.4; 28.5)</cell><cell>15.6(10.6; 21.8)</cell><cell>21.2(9.1; 27.6)</cell><cell>0.004</cell><cell>0.004</cell><cell>0.572</cell><cell>0.022</cell></row><row><cell>LPC18:2</cell><cell>32.5(25.6; 50.6)</cell><cell>19.5(9.6; 50)</cell><cell>32.1(11.6; 71.6)</cell><cell>0.005</cell><cell>0.005</cell><cell>0.67</cell><cell>0.024</cell></row><row><cell>Total PE</cell><cell>16.3(9.9; 26)</cell><cell>11.2(3.4; 23.4)</cell><cell>9.4(5; 17.6)</cell><cell>0.003</cell><cell>0.028</cell><cell>0.003</cell><cell>0.26</cell></row><row><cell>PE34:2</cell><cell>1.7(0.9; 3.2)</cell><cell>0.7(0.1; 2.3)</cell><cell>0.6(0.3; 1.8)</cell><cell>0.001</cell><cell>0.003</cell><cell>0.001</cell><cell>0.697</cell></row><row><cell>PE35:2</cell><cell>0.3(0.1; 0.5)</cell><cell>0.1(0.03; 0.3)</cell><cell>0.1(0.01; 0.2)</cell><cell>&lt;0.001</cell><cell>0.002</cell><cell>0.001</cell><cell>0.768</cell></row><row><cell>PE36:4</cell><cell>1.4(0.8; 2.7)</cell><cell>1(0.3; 2.3)</cell><cell>0.9(0.4; 2)</cell><cell>0.07</cell><cell>0.11</cell><cell>0.049</cell><cell>0.721</cell></row><row><cell>PE36:3</cell><cell>1.1(0.5; 3.1)</cell><cell>0.6(0.02; 1.3)</cell><cell>0.5(0.2; 0.8)</cell><cell>0.001</cell><cell>0.006</cell><cell>0.002</cell><cell>0.605</cell></row><row><cell>PE36:2</cell><cell>4(2.1; 8.5)</cell><cell>1.9(0.4; 5.1)</cell><cell>1.6(0.5; 3.4)</cell><cell>&lt;0.001</cell><cell>0.005</cell><cell>0.001</cell><cell>0.248</cell></row><row><cell>PE36:1</cell><cell>0.7(0.2; 2)</cell><cell>0.5(0.05; 1.1)</cell><cell>0.4(0.1; 1)</cell><cell>0.041</cell><cell>0.065</cell><cell>0.049</cell><cell>0.391</cell></row><row><cell>PE37:5</cell><cell>0.7(0.4; 1.1)</cell><cell>0.4(0.1; 0.7)</cell><cell>0.4(0.2; 1)</cell><cell>0.004</cell><cell>0.003</cell><cell>0.015</cell><cell>0.79</cell></row><row><cell>PE37:4</cell><cell>0.4(0.2; 0.8)</cell><cell>0.3(0.02; 0.6)</cell><cell>0.2(0.1; 0.4)</cell><cell>0.014</cell><cell>0.069</cell><cell>0.006</cell><cell>0.623</cell></row><row><cell>PE38:6</cell><cell>1.6(0.5; 3.7)</cell><cell>1.6(0.4; 4)</cell><cell>1.1(0.5; 2.9)</cell><cell>0.401</cell><cell>0.857</cell><cell>0.276</cell><cell>0.449</cell></row><row><cell>PE38:5</cell><cell>1.1(0.4; 2.6)</cell><cell>0.8(0.3; 2)</cell><cell>0.8(0.4; 1.8)</cell><cell>0.068</cell><cell>0.069</cell><cell>0.065</cell><cell>0.932</cell></row><row><cell>PE38:4</cell><cell>2.9(1.9; 6.3)</cell><cell>2.9(1; 5.5)</cell><cell>2.3(1.3; 4.9)</cell><cell>0.055</cell><cell>0.811</cell><cell>0.049</cell><cell>0.079</cell></row><row><cell>Total PG</cell><cell>0.3(0.1; 0.8)</cell><cell>0.3(0.1; 0.7)</cell><cell>0.2(0.1; 0.6)</cell><cell>0.099</cell><cell>0.543</cell><cell>0.108</cell><cell>0.117</cell></row><row><cell>Total PA</cell><cell>n.d.</cell><cell>n.d.</cell><cell>n.d.</cell><cell>-</cell><cell>-</cell><cell>-</cell><cell>e</cell></row><row><cell>Total SM</cell><cell>462.9(359.6; 600.4)</cell><cell>385.4(262.7; 547.9)</cell><cell>355.4(275.6; 475.7)</cell><cell>0.002</cell><cell>0.007</cell><cell>0.002</cell><cell>0.523</cell></row><row><cell>SM32:1</cell><cell>16.1(12.2; 22.6)</cell><cell>10.7(5.3; 17.8)</cell><cell>10.7(5.3; 16.4)</cell><cell>0.001</cell><cell>0.006</cell><cell>0.001</cell><cell>0.972</cell></row><row><cell>SM34:0</cell><cell>4.8(3.1; 6.1)</cell><cell>2.9(0.3; 4.5)</cell><cell>2.7(1.1; 4.2)</cell><cell>0.001</cell><cell>0.003</cell><cell>0.002</cell><cell>0.863</cell></row><row><cell>SM34:1</cell><cell>123.6(88.3; 169.2)</cell><cell>99.3(63; 131)</cell><cell>90.6(63.8; 127.6)</cell><cell>&lt;0.001</cell><cell>0.002</cell><cell>0.001</cell><cell>0.41</cell></row><row><cell>SM34:2</cell><cell>17.8(13; 23.5)</cell><cell>14.6(7.8; 27.8)</cell><cell>13.2(10.8; 20.1)</cell><cell>0.017</cell><cell>0.043</cell><cell>0.012</cell><cell>0.823</cell></row><row><cell>SM36:1</cell><cell>23.4(16.4; 33.5)</cell><cell>22(14.8; 32.3)</cell><cell>19.6(11.9; 26.4)</cell><cell>0.345</cell><cell>0.523</cell><cell>0.185</cell><cell>0.623</cell></row><row><cell>SM36:2</cell><cell>9.6(7.4; 14.7)</cell><cell>8.8(6.4; 18.8)</cell><cell>8.5(4.9; 13.1)</cell><cell>0.361</cell><cell>0.652</cell><cell>0.231</cell><cell>0.482</cell></row><row><cell>SM38:1</cell><cell>23.2(15.8; 28.2)</cell><cell>17.9(12.3; 26.5)</cell><cell>16.9(12.2; 21.7)</cell><cell>0.006</cell><cell>0.04</cell><cell>0.006</cell><cell>0.286</cell></row><row><cell>SM39:1</cell><cell>9.2(5.9; 11.7)</cell><cell>6.8(4.3; 11.3)</cell><cell>5.6(4.3; 10.6)</cell><cell>0.005</cell><cell>0.028</cell><cell>0.004</cell><cell>0.499</cell></row><row><cell>SM39:2</cell><cell>1.2(0.5; 2.2)</cell><cell>1(0.3; 2.2)</cell><cell>0.9(0.3; 1.8)</cell><cell>0.371</cell><cell>0.435</cell><cell>0.29</cell><cell>0.566</cell></row><row><cell>SM40:1</cell><cell>42.6(31.7; 59.8)</cell><cell>33.7(25.9; 47.4)</cell><cell>32(22.2; 44.8)</cell><cell>0.004</cell><cell>0.015</cell><cell>0.004</cell><cell>0.697</cell></row><row><cell>SM40:2</cell><cell>28(18.6; 35.8)</cell><cell>23.1(16.4; 36.1)</cell><cell>21(16.9; 37.2)</cell><cell>0.017</cell><cell>0.026</cell><cell>0.022</cell><cell>0.681</cell></row><row><cell>SM41:1</cell><cell>22.2(17; 32.9)</cell><cell>19.3(9.7; 28.3)</cell><cell>15.4(13.3; 21.9)</cell><cell>0.001</cell><cell>0.016</cell><cell>0.001</cell><cell>0.314</cell></row><row><cell>SM41:2</cell><cell>14(11.6; 23.1)</cell><cell>12(7.3; 17.3)</cell><cell>11.8(8; 20.6)</cell><cell>0.049</cell><cell>0.043</cell><cell>0.065</cell><cell>0.823</cell></row><row><cell>SM42:1</cell><cell>39.6(25.8; 53.1)</cell><cell>29.8(19; 42.5)</cell><cell>25.8(19.1; 40.2)</cell><cell>0.005</cell><cell>0.03</cell><cell>0.005</cell><cell>0.327</cell></row><row><cell>SM42:2</cell><cell>66.4(51.6; 82.8)</cell><cell>53.6(40.9; 77.6)</cell><cell>55.3(38.4; 79.6)</cell><cell>0.016</cell><cell>0.018</cell><cell>0.026</cell><cell>0.823</cell></row><row><cell>SM42:3</cell><cell>22.8(16.7; 33.4)</cell><cell>21.4(15.3; 30.9)</cell><cell>21.5(13.6; 36.8)</cell><cell>0.38</cell><cell>0.324</cell><cell>0.326</cell><cell>0.811</cell></row><row><cell>Total Cer/HexCer</cell><cell>12.2(4.9; 20.2)</cell><cell>8.5(2.8; 11.7)</cell><cell>5.4(3.1; 7.4)</cell><cell>&lt;0.001</cell><cell>0.013</cell><cell>0.001</cell><cell>0.026</cell></row><row><cell>Cer(d18:1/24:0)</cell><cell>2.2(1.4; 4.9)</cell><cell>1.7(1; 2.6)</cell><cell>1.6(0.7; 2.7)</cell><cell>0.041</cell><cell>0.04</cell><cell>0.049</cell><cell>0.932</cell></row><row><cell cols="2">HexCer(d18:1/22:0) 2.8(0.9; 5)</cell><cell>1.9(0.3; 3)</cell><cell>1.1(0.3; 1.7)</cell><cell>&lt;0.001</cell><cell>0.033</cell><cell>0.001</cell><cell>0.01</cell></row><row><cell cols="2">HexCer(d18:1/23:0) 1.5(0.5; 2.9)</cell><cell>0.8(0.2; 1.7)</cell><cell>0.6(0.2; 1.1)</cell><cell>0.001</cell><cell>0.016</cell><cell>0.001</cell><cell>0.117</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">(continued on next page)</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Published in final edited form as: Atherosclerosis. 2016 Mar;246:130-40. doi: 10.1016/j.atherosclerosis.2016.01.003</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>The authors thank all physicians and nurses involved in the SPUM-ACS study and the participants for their contribution to the study and blood sample donation.</s><s>The authors wish to thank Silvia Radosavljevic for the isolation of the lipoprotein fractions.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Disclosures</head><p><s>The authors have no conflict of interest pertinent to the subject of this study.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Funding</head><p><s>TH received a grant from the Zurich Center of Integrated Human Physiology, University of Zurich (ZIHP).</s><s>AvE was supported by the Foundation for Pathobiochemistry and Molecular Diagnostics of the German Society for Clinical Chemistry and Laboratory Medicine.</s><s>The SPUM-ACS study (RK, UL, DH, NR, FM, SW, CMM, TFL) was funded by the Swiss National Science Foundation (SPUM 33CM30-124112); Swiss Heart Foundation; Fondation Leducq and the Foundation for Cardiovascular Research, Zurich.</s><s>The SPUM consortium was supported by Roche, Eli Lilly (USA), AstraZeneca, Medtronic, MSD, Sanofi, St. Jude Medical (all Switzerland).</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Cardiovascular disease in Europe 2014: epidemiological update</title>
		<author>
			<persName><forename type="first">M</forename><surname>Nichols</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Townsend</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Scarborough</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rayner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur. Heart J</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">42</biblScope>
			<biblScope unit="page">2929</biblScope>
			<date type="published" when="2014-11-07">Nov 7 2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Progress and challenges in translating the biology of atherosclerosis</title>
		<author>
			<persName><forename type="first">P</forename><surname>Libby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Ridker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Hansson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">473</biblScope>
			<biblScope unit="issue">7347</biblScope>
			<biblScope unit="page" from="317" to="e325" />
			<date type="published" when="2011-05-19">May 19 2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Pathogenesis of acute coronary syndromes</title>
		<author>
			<persName><forename type="first">F</forename><surname>Crea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Liuzzo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Am. Coll. Cardiol</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="e11" />
			<date type="published" when="2013-01-08">Jan 8 2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Lipidomics: a tool for studies of atherosclerosis</title>
		<author>
			<persName><forename type="first">K</forename><surname>Ekroos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Janis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tarasov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hurme</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Laaksonen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr. Atheroscler. Rep</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="273" to="e281" />
			<date type="published" when="2010-07">Jul 2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Sphingolipids and atherosclerosis</title>
		<author>
			<persName><forename type="first">T</forename><surname>Hornemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Worgall</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Atherosclerosis</title>
		<imprint>
			<biblScope unit="volume">226</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="16" to="e28" />
			<date type="published" when="2013-01">Jan 2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry</title>
		<author>
			<persName><forename type="first">P</forename><surname>Wiesner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Leidl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Boettcher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Schmitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Liebisch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Lipid Res</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="574" to="e585" />
			<date type="published" when="2009-03">Mar 2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">A phospholipidomic analysis of all defined human plasma lipoproteins</title>
		<author>
			<persName><forename type="first">M</forename><surname>Dashti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Kulik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Hoek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Veerman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Peppelenbosch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Rezaee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci. Rep</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page">139</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Blood sphingolipidomics in healthy humans: impact of sample collection methodology</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Hammad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Pierce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Soodavar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Lipid Res</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="3074" to="e3087" />
			<date type="published" when="2010-10">Oct 2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Plasma lipidomic analysis of stable and unstable coronary artery disease</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Meikle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Tsorotes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arterioscler. Thromb. Vasc. Biol</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="2723" to="e2732" />
			<date type="published" when="2011-11">Nov 2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Serum choline plasmalogens-those with oleic acid in sn-2-are biomarkers for coronary artery disease</title>
		<author>
			<persName><forename type="first">M</forename><surname>Nishimukai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Maeba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ikuta</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin. Chim. Acta</title>
		<imprint>
			<biblScope unit="volume">437</biblScope>
			<biblScope unit="page" from="147" to="e154" />
			<date type="published" when="2014-11-01">Nov 1 2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Comparative analysis of lipid composition of normal and acute-phase high density lipoproteins</title>
		<author>
			<persName><forename type="first">W</forename><surname>Pruzanski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Stefanski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>De Beer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>De Beer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ravandi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kuksis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Lipid Res</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1035" to="e1047" />
			<date type="published" when="2000-07">Jul 2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">NMR-based lipidomic analysis of blood lipoproteins differentiates the progression of coronary heart disease</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Kostara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Papathanasiou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Psychogios</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Proteome Res</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">5</biblScope>
			<date type="published" when="2014-05-02">May 2 2014. 2585e2598</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Plasmalogens of high-density lipoproteins (HDL) are associated with coronary artery disease and anti-apoptotic activity of HDL</title>
		<author>
			<persName><forename type="first">I</forename><surname>Sutter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Velagapudi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Othman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Atherosclerosis</title>
		<imprint>
			<biblScope unit="volume">241</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="539" to="e546" />
			<date type="published" when="2015-08">Aug 2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Lipidomics as a tool for the study of lipoprotein metabolism</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kontush</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Chapman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr. Atheroscler. Rep</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="194" to="e201" />
			<date type="published" when="2010-05">May 2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Comparative lipidomics profiling of human atherosclerotic plaques</title>
		<author>
			<persName><forename type="first">C</forename><surname>Stegemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Drozdov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Shalhoub</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ. Cardiovasc Genet</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="232" to="e242" />
			<date type="published" when="2011-06">Jun 2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Many ceramides</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">A</forename><surname>Hannun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Obeid</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">286</biblScope>
			<biblScope unit="issue">32</biblScope>
			<date type="published" when="2011-08-12">Aug 12 2011) 27855e27862</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids</title>
		<author>
			<persName><forename type="first">A</forename><surname>Penno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Reilly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Houlden</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">285</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="11178" to="e11187" />
			<date type="published" when="2010-04-09">Apr 9 2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Ceramide synthase inhibition by fumonisin B1 causes accumulation of 1-deoxysphinganine: a novel category of bioactive 1-deoxysphingoid bases and 1-deoxydihydroceramides biosynthesized by mammalian cell lines and animals</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">C</forename><surname>Zitomer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Mitchell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Voss</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">284</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="4786" to="e4795" />
			<date type="published" when="2009-02-20">Feb 20 2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Circulating FABP4 is a prognostic biomarker in patients with acute coronary syndrome but not in asymptomatic individuals</title>
		<author>
			<persName><forename type="first">H</forename><surname>Reiser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Klingenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hof</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arterioscler. Thromb. Vasc. Biol</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1872" to="e1879" />
			<date type="published" when="2015-08">Aug 2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">ATP-Binding cassette transporter A1 modulates apolipoprotein A-I transcytosis through aortic endothelial cells</title>
		<author>
			<persName><forename type="first">C</forename><surname>Cavelier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Rohrer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Eckardstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ. Res</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1060" to="e1066" />
			<date type="published" when="2006-11-10">Nov 10 2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Software tools for analysis of mass spectrometric lipidome data</title>
		<author>
			<persName><forename type="first">P</forename><surname>Haimi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Uphoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hermansson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Somerharju</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anal. Chem</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="issue">24</biblScope>
			<biblScope unit="page" from="8324" to="e8331" />
			<date type="published" when="2006-12-15">Dec 15 2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Apolipoprotein M modulates erythrocyte efflux and tubular reabsorption of sphingosine-1-phosphate</title>
		<author>
			<persName><forename type="first">I</forename><surname>Sutter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Othman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Lipid Res</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1730" to="e1737" />
			<date type="published" when="2014-06-20">Jun 20 2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Plasma deoxysphingolipids: a novel class of biomarkers for the metabolic syndrome</title>
		<author>
			<persName><forename type="first">A</forename><surname>Othman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Rutti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ernst</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetologia</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="421" to="e431" />
			<date type="published" when="2012-02">Feb 2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Resampling-based false discovery rate controlling multiple test procedures for correlated test statistics</title>
		<author>
			<persName><forename type="first">D</forename><surname>Yekutieli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Benjamini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Stat. Plan. Inference</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="issue">1e2</biblScope>
			<biblScope unit="page" from="171" to="e196" />
			<date type="published" when="1999-12-01">Dec 1 1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients</title>
		<author>
			<persName><forename type="first">J</forename><surname>Graessler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Schwudke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Schwarz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Herzog</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Shevchenko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Bornstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page">e6261</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effectsea monozygotic twin study</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Pietilainen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sysi-Aho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rissanen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">e218</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Genomic, transcriptomic, and lipidomic profiling highlights the role of inflammation in individuals with low high-density lipoprotein cholesterol</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Laurila</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Surakka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Sarin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arterioscler. Thromb. Vasc. Biol</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="847" to="e857" />
			<date type="published" when="2013-04">Apr 2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Plasmalogens in human serum positively correlate with high-density lipoprotein and decrease with aging</title>
		<author>
			<persName><forename type="first">R</forename><surname>Maeba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Maeda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kinoshita</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Atheroscler. Thromb</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="12" to="e18" />
			<date type="published" when="2007-02">Feb 2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Plasmalogens the neglected regulatory and scavenging lipid species</title>
		<author>
			<persName><forename type="first">S</forename><surname>Wallner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Schmitz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chem. Phys. Lipids</title>
		<imprint>
			<biblScope unit="volume">164</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="573" to="e589" />
			<date type="published" when="2011-09">Sep 2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Delayed oxidative degradation of polyunsaturated diacyl phospholipids in the presence of plasmalogen phospholipids in vitro</title>
		<author>
			<persName><forename type="first">D</forename><surname>Reiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Beyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Engelmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. J</title>
		<imprint>
			<biblScope unit="volume">323</biblScope>
			<biblScope unit="page" from="807" to="e814" />
			<date type="published" when="1997-05-01">May 1 1997</date>
		</imprint>
	</monogr>
	<note>Pt 3</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Delay of copper-catalyzed oxidation of low density lipoprotein by in vitro enrichment with choline or ethanolamine plasmalogens</title>
		<author>
			<persName><forename type="first">G</forename><surname>Jurgens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ledinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Paltauf</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chem. Phys. Lipids</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="25" to="e31" />
			<date type="published" when="1995-08-01">Aug 1 1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Ethanolamine plasmalogens prevent the oxidation of cholesterol by reducing the oxidizability of cholesterol in phospholipid bilayers</title>
		<author>
			<persName><forename type="first">R</forename><surname>Maeba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ueta</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Lipid Res</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="164" to="e171" />
			<date type="published" when="2003-01">Jan 2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Deoxysphingoid bases as plasma markers in diabetes mellitus</title>
		<author>
			<persName><forename type="first">M</forename><surname>Bertea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Rutti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Othman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lipids Health Dis</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">84</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Lipidomics reveals a remarkable diversity of lipids in human plasma</title>
		<author>
			<persName><forename type="first">O</forename><surname>Quehenberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Armando</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Brown</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Lipid Res</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="3299" to="e3305" />
			<date type="published" when="2010-11">Nov 2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Sattler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Elbasan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Keul</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Basic Res. Cardiol</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="821" to="e832" />
			<date type="published" when="2010-11">Nov 2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Argraves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Sethi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Gazzolo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lipids Health Dis</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">70</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Luscher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Landmesser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Eckardstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Fogelman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ. Res</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="171" to="e182" />
			<date type="published" when="2014-01-03">Jan 3 2014</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
